{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:43:02Z","timestamp":1772152982516,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>We describe the clinicopathologic features of 17 patients who had a hematologic malignancy of various types, were treated, and subsequently developed a lymphoproliferative disorder (LPD). There were 10 men and 7 women with a median age of 59 years (range, 36 to 83\u2009y). The primary hematologic neoplasms included: 5 chronic lymphocytic leukemia\/small lymphocytic lymphoma, 3 plasma cell myeloma, 2 acute monoblastic leukemia, and 1 case each of mixed-phenotype acute leukemia, chronic myeloid leukemia, splenic marginal zone lymphoma, follicular lymphoma, mantle cell lymphoma, T-cell prolymphocytic leukemia, and peripheral T-cell lymphoma. All patients were treated with chemotherapy with or without therapeutic antibodies; 3 also underwent autologous stem cell transplantation. The mean interval from initiation of therapy for initial hematologic malignancy to onset of LPD was 66 months (range, 3 to 299\u2009mo). Ten (59%) LPDs were extranodal and 7 (41%) involved nodal tissues. The histologic diagnoses included: 8 diffuse large B-cell lymphoma, 4 classical Hodgkin lymphoma, 3 polymorphic LPD, 1 lymphomatoid granulomatosis, and 1 Epstein-Barr virus (EBV)<jats:sup>+<\/jats:sup> mucocutaneous ulcer. Fourteen cases were EBV<jats:sup>+<\/jats:sup>. Following the onset of LPD, chemotherapy was administered to 10 (59%) patients. With a median follow-up of 100 months (range, 5 to 328\u2009mo), 8 (47%) patients are alive and 9 (53%) died. One (6%) patient with lymphomatoid granulomatosis underwent spontaneous remission. On the basis of the clinicopathologic features and high prevalence of EBV infection in this cohort, we believe that these LPDs show similarities with other types of immunodeficiency-associated LPDs. We suggest that cancer therapy-associated LPD be included in future classification systems for immunodeficiency-associated LPDs.<\/jats:p>","DOI":"10.1097\/pas.0000000000000954","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T21:15:29Z","timestamp":1510780529000},"page":"116-129","source":"Crossref","is-referenced-by-count":33,"title":["Cancer Therapy-associated Lymphoproliferative Disorders"],"prefix":"10.1097","volume":"42","author":[{"given":"Sergio","family":"Pina-Oviedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230922","first-page":"200","article-title":"Immunodeficiency-associated lymphoproliferative disorders","volume":"12","author":"Knowles","year":"1999","journal-title":"Mod Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00000478-200205000-00009","article-title":"Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms","volume":"26","author":"Abruzzo","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clml.2012.10.002","article-title":"Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine","volume":"13","author":"Bhamidipati","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2141.1997.2153034.x","article-title":"Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia","volume":"98","author":"Briz","year":"1997","journal-title":"Br J Haematol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2012.09202.x","article-title":"Therapy-related classical Hodgkin lymphoma after a primary haematological malignancy: a report on 13 cases","volume":"158","author":"Cheminant","year":"2012","journal-title":"Br J Haematol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.2005.05426.x","article-title":"Hodgkin\u2019s disease variant of Richter\u2019s syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine","volume":"129","author":"Fong","year":"2005","journal-title":"Br J Haematol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.humpath.2010.04.019","article-title":"Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia\/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus","volume":"41","author":"Foo","year":"2010","journal-title":"Hum Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3892\/ol.2012.670","article-title":"Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin\u2019s lymphoma","volume":"3","author":"Izumiya","year":"2012","journal-title":"Oncol Lett"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3109\/10428194.2013.773995","article-title":"Spontaneous remission of chemo-immunotherapy related, non-transplant Epstein-Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia","volume":"54","author":"Jain","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R13-20230922","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200079","article-title":"The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers?","author":"Kilner","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2008-02-138800","article-title":"EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma","volume":"112","author":"Kluin-Nelemans","year":"2008","journal-title":"Blood"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1055-9965.EPI-06-1069","article-title":"Non-Hodgkin lymphoma secondary to cancer chemotherapy","volume":"16","author":"Krishnan","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/sj.leu.2404758","article-title":"EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia","volume":"21","author":"Leguay","year":"2007","journal-title":"Leukemia"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hon.2054","article-title":"Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia","volume":"32","author":"Menter","year":"2014","journal-title":"Hematol Oncol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJM199907013410112","article-title":"Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine","volume":"341","author":"Niesvizky","year":"1999","journal-title":"N Engl J Med"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2141.2001.02579.x","article-title":"Epstein-Barr virus-positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma","volume":"112","author":"Orlandi","year":"2001","journal-title":"Br J Haematol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1701335","article-title":"A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation","volume":"22","author":"Peniket","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2009.24.4194","article-title":"Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia","volume":"28","author":"Sohani","year":"2010","journal-title":"J Clin Oncol"},{"key":"R22-20230922","first-page":"4400","article-title":"Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R23-20230922","article-title":"Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up","author":"Tadmor","year":"2016","journal-title":"Hematol Oncol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/10428194.2016.1217527","article-title":"Secondary malignancies in patients with multiple myeloma, Waldenstrom macroglobulinemia and monoclonal gammopathy of undetermined significance","volume":"58","author":"Castillo","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/leu.2016.20","article-title":"Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV","volume":"30","author":"Miranda","year":"2016","journal-title":"Leukemia"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2011-06-362889","article-title":"Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies","volume":"118","author":"Verma","year":"2011","journal-title":"Blood"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12185-015-1802-4","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21)","volume":"102","author":"Higuchi","year":"2015","journal-title":"Int J Hematol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12308-016-0273-8","article-title":"Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients","volume":"9","author":"Morscio","year":"2016","journal-title":"Journal of Hematopathology"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajcp\/aqw200","article-title":"Immunodeficiency and dysregulation: report of the 2015 Workshop of the Society for Hematopathology\/European Association for Haematopathology","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.07.025","article-title":"Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature","volume":"58","author":"Miao","year":"2016","journal-title":"Hum Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/PAS.0b013e31828e6564","article-title":"Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases","volume":"37","author":"Loo","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1365-2141.1999.01765.x","article-title":"The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders","volume":"107","author":"Lazzarino","year":"1999","journal-title":"Br J Haematol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.bmt.1701258","article-title":"Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases","volume":"21","author":"Hauke","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10875-014-9995-5","article-title":"Antibody deficiency secondary to chronic lymphocytic leukemia: should patients be treated with prophylactic replacement immunoglobulin?","volume":"34","author":"Dhalla","year":"2014","journal-title":"J Clin Immunol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/CCO.0b013e32834bcc2a","article-title":"Therapy-related myeloid neoplasms","volume":"23","author":"Leone","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2009.06.002","article-title":"The role of immunity in elderly cancer","volume":"74","author":"Malaguarnera","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1182\/blood-2004-07-2527","article-title":"Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner","volume":"105","author":"Seggewiss","year":"2005","journal-title":"Blood"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00262-016-1882-x","article-title":"Immunosenescence: limitations of natural killer cell-based cancer immunotherapy","volume":"66","author":"Tarazona","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.intimp.2013.05.021","article-title":"Tumor-induced host immunosuppression: special focus on CLL","volume":"17","author":"Cutucache","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ACI.0000000000000215","article-title":"Secondary antibody deficiencies","volume":"15","author":"Dhalla","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hon.2323","article-title":"Secondary immunodeficiency in lymphoproliferative malignancies","volume":"34","author":"Friman","year":"2016","journal-title":"Hematol Oncol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2015-03-567388","article-title":"Perturbation of the normal immune system in patients with CLL","volume":"126","author":"Forconi","year":"2015","journal-title":"Blood"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bmt.1704402","article-title":"An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma","volume":"33","author":"Powell","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-15-2242","article-title":"Lenalidomide, thalidomide, and pomalidomide reactivate the Epstein-Barr virus lytic cycle through phosphoinositide 3-kinase signaling and ikaros expression","volume":"22","author":"Jones","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R45-20230922","article-title":"Post-transplant lymphoproliferative disorder: a heterogeneous conundrum","author":"Weisenburger","year":"2016","journal-title":"Br J Haematol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3109\/10428194.2015.1022769","article-title":"Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal","volume":"56","author":"Inui","year":"2015","journal-title":"Leuk Lymphoma"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201801000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:21:05Z","timestamp":1695421265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201801000-00014"}},"subtitle":["An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder"],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000954","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}